Eli Lilly Nears $1 Trillion Valuation

This is a news story, published by Yahoo Finance, that relates primarily to Johnson & Johnson news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

pharmaceutical stocks

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest few pharmaceutical stocks news, largest drug companies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

pharma stocks

The Motley Fool

•

This Undervalued Stock Could Join the Race With Eli Lilly to the $1 Trillion Club

Summary

Nutrition label

82% Informative

Johnson & Johnson ( NYSE : JNJ ) is on track to hit $1 trillion for investors who have a long-enough time horizon.

Eli Lilly's market cap is $850 billion , and it seems certain to cross the trillion-dollar threshold soon.

The company's valuation isn't incredibly cheap -- it's unusual for high-profile stocks to trade at irrational prices.

The pharmaceutical industry is worth a look for any long-term investors looking for a value stock.

Over the past few years , the market moved away from healthcare and pharmaceutical stocks that boomed starting in 2020 .

Johnson & Johnson is a good candidate over the long term for the trillion-dollar threshold.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

https://ycharts.com/companies/JNJ/dividend_yield https://www.fool.com/investing/2024/08/22/this-undervalued-stock-could-join-the-race-with-el/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=3f1244ac-4ce6-4955-a3c5-a6e0403da5c0 https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=93129e3b-ffab-4ebd-8b3e-5f913b8355c0&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26source%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_pit%3D13885%26ftm_veh%3Darticle_pitch_feed_yahoo%26company%3DJohnson%2520%2526%2520Johnson&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=3f1244ac-4ce6-4955-a3c5-a6e0403da5c0 https://www.fool.com/author/20170/https://ycharts.com/companies/JNJ/forward_ev_ebitda https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=93129e3b-ffab-4ebd-8b3e-5f913b8355c0&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26amp%253Bsource%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_veh%3Darticle_pitch_feed_yahoo%26ftm_pit%3D13885&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=3f1244ac-4ce6-4955-a3c5-a6e0403da5c0 https://www.fool.com/legal/fool-disclosure-policy/https://ycharts.com https://www.fool.com/investing/stock-market/market-sectors/healthcare/pharmaceutical-stocks/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=3f1244ac-4ce6-4955-a3c5-a6e0403da5c0 https://www.fool.com/investing/value/2005/12/27/capital-structure-explained.aspx ?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=3f1244ac-4ce6-4955-a3c5-a6e0403da5c0

Source diversity

ycharts.com www.fool.com api.fool.com

Affiliate links

no affiliate links

Read full article